Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_37762 | 25 | 0.51 | Mlig455_024925, Mlig455_024958 | Neo: - Age: - Region-enriched R2: 10.314/0.00053 |
CHRNA7 | Mlig455_024925 {REF} {Length: 1846} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=135.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=118.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=8e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=5e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=217, Expect=6e-64]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=211, Expect=1e-61]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=218, Expect=3e-64]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=213, Expect=1e-62]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=209, Expect=5e-61]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=232, Expect=6e-69]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=219, Expect=3e-65]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=205, Expect=3e-59]} {RNA1310_18666.1} {RNA815_22720} Mlig455_024958 {REF} {Length: 3129} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=135.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=118.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=8e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=5e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=217, Expect=6e-64]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=211, Expect=1e-61]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=218, Expect=3e-64]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=213, Expect=1e-62]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=209, Expect=5e-61]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=232, Expect=6e-69]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=219, Expect=3e-65]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=205, Expect=3e-59]} {RNA1509_23224, RNA1509_43289} {RNA1310_18666.1, RNA1509_23224, RNA1509_43289} {RNA1509_23224, RNA1509_43289, RNA815_22720} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -12.215 | 0.704 | 0.99958 | 1.00000 | |
RegionR2 | 10.314 | 0.704 | 0.00001 | 0.00053 | |
RegionR3 | 3.387 | 0.704 | 0.08155 | 0.50514 | |
RegionR4 | -4.113 | 0.704 | 0.99962 | 1.00000 | |
RegionR5 | -0.338 | 0.704 | 1.00000 | 1.00000 | |
RegionR6 | 3.442 | 0.704 | 0.08441 | 0.53557 | |
RegionR7 | 0.876 | 0.704 | 0.99972 | 1.00000 | |
RegionR8 | -1.352 | 0.704 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 10.758 | 0.704 | 0.99984 | 1.00000 | |
RegenerationR2 | -0.657 | 0.704 | 0.40436 | 0.81677 | |
RegenerationR3 | 4.517 | 0.704 | 0.13233 | 0.55602 | |
RegenerationR4 | 3.395 | 0.704 | 0.19288 | 0.63772 | |
RegenerationR5 | 1.926 | 0.704 | 0.99986 | 1.00000 | |
RegenerationR6 | 2.014 | 0.704 | 0.41211 | 0.74542 | |
RegenerationBL | 4.892 | 0.704 | 0.20887 | 0.55165 | |
RegenerationTP | 1.585 | 0.704 | 0.99985 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_37762 | 25 | 0.51 | Mlig455_024925, Mlig455_024958 | Neo: - Age: - Region-enriched R2: 10.314/0.00053 |
CHRNA7 | 1 | - | - | - | - | 1.000 | - | Mlig455_024925 {REF} {Length: 1846} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=135.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=118.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=8e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=5e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=217, Expect=6e-64]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=211, Expect=1e-61]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=218, Expect=3e-64]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=213, Expect=1e-62]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=209, Expect=5e-61]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=232, Expect=6e-69]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=219, Expect=3e-65]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=205, Expect=3e-59]} {RNA1310_18666.1} {RNA815_22720} Mlig455_024958 {REF} {Length: 3129} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=135.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=118.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=8e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=5e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=217, Expect=6e-64]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=211, Expect=1e-61]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=218, Expect=3e-64]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=213, Expect=1e-62]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=209, Expect=5e-61]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=232, Expect=6e-69]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=219, Expect=3e-65]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=205, Expect=3e-59]} {RNA1509_23224, RNA1509_43289} {RNA1310_18666.1, RNA1509_23224, RNA1509_43289} {RNA1509_23224, RNA1509_43289, RNA815_22720} |
2. | MligTC455_27648 | 19 | 0.39 | Mlig455_044670 | Neo: - |
SZT2 | 0.983 | - | - | - | - | 0.983 | - | Mlig455_044670 {REF} {Length: 12113} {Human: ENSG00000198198, SZT2, SZT2, KICSTOR complex subunit, [Score=82.4, Expect=2e-14]} {Mouse: ENSMUSG00000033253, Szt2, seizure threshold 2, [Score=74.3, Expect=4e-12]} {Smed: dd_Smed_v6_8946_0_1, dd_Smed_v6_8946_0_1, [Score=108, Expect=9e-23]} {RNA1509_25909} {RNA1310_92.1} {RNA815_13061} |
3. | MligTC455_09063 | 16 | 0.32 | Mlig455_064012 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_064012 {REF} {Length: 6137} {Pfam: PHD-finger [PF00628.31, score=56.5]; Endonuclease-reverse transcriptase [PF14529.8, score=43.5]; Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=42.1]; Reverse transcriptase-like [PF13456.8, score=26.8]; Prokaryotic RING finger family 1 [PF14446.8, score=20.9]} {RNA1310_20747.1} |